SYK · News · 20260909N
Guidance / Outlook
STRYKER CORP · 2026-09-09 · Importance 51 · Surprise 60 · In source text
Stryker reportedly raised its full-year 2026 guidance after reporting second-quarter 2026 results that exceeded expectations. Wells Fargo subsequently reduced its 2026 revenue and EPS estimates below Stryker’s guidance, citing concerns about future revenue growth. BMO also reduced its forecasts for third-quarter organic growth, sales, and full-year 2026 sales and EPS after commentary from Stryker at a healthcare conference.
Key facts
- Stryker recently reported Q2 2026 results that exceeded expectations and raised its full-year guidance. source
- Stryker exceeded quarterly EPS and revenue estimates when it reported results. source
- Stryker provided commentary at a recent competitor conference that led analysts to revise estimates for third-quarter organic growth, sales, and full-year 2026 sales and EPS. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Stryker recently reported Q2 2026 results that exceeded expectations and raised its full-year guidance. |
| revenue | positive | probable | — | Stryker recently reported Q2 2026 results that exceeded expectations and raised its full-year guidance. |